Enliven Therapeutics (ELVN) Other Accumulated Expenses (2022 - 2026)
Enliven Therapeutics' Other Accumulated Expenses was $133,000 in Q2 2026, up 111.1% from $63,000 a year earlier and up 24.3% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025, Other Accumulated Expenses at Enliven Therapeutics came in at $351,000, up 72.1% from FY2024.
- Other Accumulated Expenses shows a three-year compound annual growth rate of -7.7% (FY2022 to FY2025).
- In earlier years, Other Accumulated Expenses was $204,000 in FY2024 (-44.0%), $364,000 in FY2023 (-18.6%) and $447,000 in FY2022.
- Quarterly Other Accumulated Expenses has moved between $63,000 (Q2 2025) and $548,000 (Q1 2023) over five years.
- Compared with a year earlier, Other Accumulated Expenses was higher in two of the last eight quarters, with an average decline of 16.8%.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q2 2026 (growth of 111.1%); the worst was Q2 2025 (a decline of 78.4%).
- Per Business Quant data, ELVN's Other Accumulated Expenses in the three quarters before Q2 2026 was $107,000 (Q1 2026), $351,000 (Q4 2025) and $86,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Enliven Therapeutics | 3.44 Bn | 3.44 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133,000.00 |
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | 351,000.00 |
| Sep 30, 2025 | 86,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Mar 31, 2025 | 146,000.00 |
| Dec 31, 2024 | 204,000.00 |
| Sep 30, 2024 | 216,000.00 |
| Jun 30, 2024 | 291,000.00 |
| Mar 31, 2024 | 446,000.00 |
| Dec 31, 2023 | 364,000.00 |
| Sep 30, 2023 | 368,000.00 |
| Jun 30, 2023 | 343,000.00 |
| Mar 31, 2023 | 548,000.00 |
| Dec 31, 2022 | 447,000.00 |
API Access
Enliven Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();